RecruitingNot ApplicableNCT07684508

Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer

Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Postoperative Cervical Cancer (AMICA-CC) : a Prospective, Multicenter, Phase II Trial

Sponsor

Manni Huang

Enrollment

154 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Cervical Cancers Hypofractionated Radiotherapy Intensity Modulated Radiotherapy

Summary

To investigate the safety and efficacy of moderately hypofractionated intensity-modulated radiotherapy in the treatment of postoperative cervical cancer

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Postoperative Radiotherapy for people with cervical cancers, hypofractionated radiotherapy, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONPostoperative Radiotherapy

Postoperative moderately hypofractionated IMRT (2.5Gy per fraction, 17 fractions, once a day)

Locations(2)

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

Lang Fang Campus of Cancer Hospital, Chinese Academy of Medical Sciences

Langfang, Hebei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07684508

Related Trials

Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）

NCT051679941 location

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

NCT0679963724 locations